Pharmacokinetics and Bioequivalence of Memantine Tablet and a New Dry Syrup Formulation in Healthy Japanese Males: Two Single-Dose Crossover Studies

INTRODUCTION: Memantine hydrochloride, an N-methyl-D-aspartate receptor antagonist, is used to treat Alzheimer’s disease (AD). A new dry syrup formulation containing memantine hydrochloride has been developed to improve medication adherence in AD patients and to reduce family and caregiver burden. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Maekawa, Yutaro, Hasegawa, Setsuo, Ishizuka, Tomoko, Shiosakai, Kazuhito, Ishizuka, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822834/
https://www.ncbi.nlm.nih.gov/pubmed/31399883
http://dx.doi.org/10.1007/s12325-019-01044-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822834/
https://www.ncbi.nlm.nih.gov/pubmed/31399883
http://dx.doi.org/10.1007/s12325-019-01044-y

Ejemplares similares